| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |